Andere Sprachen Chiome Bioscience Inc.

Aktien

A1JTP0

JP3205350006

4583

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 30.04.2024			% 5 Tage	% 1. Jan.
124 ^JPY	+0.81%		-3.88%	-8.15%

13.02.	Chiome Bioscience Inc. kündigt Betrauungsvertrag mit Takeda Pharmaceutical Company Limited an	CI
13.02.	Chiome Bioscience Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Chiome Bioscience Cancels License Agreements with ADC Therapeutics	01.04.
Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	13.02.
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.02.
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	14.11.
Chiome Bioscience Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09.08.23
Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.	20.07.23
Chiome Bioscience Inc. announced that it expects to receive Â¥13.49304 million in funding	04.07.23
Chiome Bioscience Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11.05.23
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14.02.23
Chiome Bioscience Inc. Provided Sales Guidance for 2023	14.02.23
Henlius Biotech Terminates License Agreement for Chiome Bioscience's Tumor Drug	17.01.23
Chiome Bioscience Inc. Announces Termination of the License Agreement for Anti-TROP-2 Antibody Development and Commercialization with Shanghai Henlius Biotech, Inc	17.01.23
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	14.11.22
Chiome Bioscience Reports Results of Cancer Immunotherapy Joint Research	09.09.22
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma	14.07.22
Heidelberg Pharma Enters Research Collaboration Deal With Japan's Chiome Bioscience	13.07.22
Chiome Bioscience : Announcement of target-specific research and option agreement with Heidelberg Pharma	13.07.22
Chiome Bioscience Inc. Announces Conclusion of Target-Specific Research and Option Agreement with Heidelberg Pharma	13.07.22
Japan Index Snaps Three-day Winning Streak on Inflationary Pressures; Kudan Shares Expand 7%	12.07.22
Chiome Bioscience, Rohto Pharmaceutical Sign Deal for Generation of Therapeutic Antibody	12.07.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Chiome Bioscience Inc.

Aktien

A1JTP0

JP3205350006

4583

Andere Sprachen

Filter